• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Hydrazines and derivatives Alkylhydrazines

Recent Advances in the Application of (Cyclopropylmethyl)hydrazine Hydrochloride (CAS: 1181457-83-9) in Chemical Biology and Pharmaceutical Research

(Cyclopropylmethyl)hydrazine hydrochloride (CAS: 1181457-83-9) is a specialized chemical compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its cyclopropylmethyl hydrazine moiety, serves as a key intermediate in the synthesis of various biologically active molecules. Recent studies have highlighted its potential in drug discovery, particularly in the development of enzyme inhibitors and targeted therapeutics. The unique structural features of (cyclopropylmethyl)hydrazine hydrochloride enable it to participate in diverse chemical reactions, making it a valuable tool for medicinal chemists.

One of the most notable applications of (cyclopropylmethyl)hydrazine hydrochloride is its role in the synthesis of monoamine oxidase (MAO) inhibitors. MAO enzymes are critical targets for the treatment of neurological disorders such as Parkinson's disease and depression. Recent research published in the Journal of Medicinal Chemistry (2023) demonstrated that derivatives synthesized using (cyclopropylmethyl)hydrazine hydrochloride exhibited potent and selective inhibition of MAO-B, with improved pharmacokinetic properties compared to existing drugs. These findings suggest that this compound could pave the way for next-generation neurotherapeutics with enhanced efficacy and reduced side effects.

In addition to its applications in neurology, (cyclopropylmethyl)hydrazine hydrochloride has shown promise in oncology research. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported the use of this compound in the development of novel histone deacetylase (HDAC) inhibitors. HDAC inhibitors are a class of anticancer agents that modulate gene expression by altering chromatin structure. The study revealed that (cyclopropylmethyl)hydrazine hydrochloride-derived HDAC inhibitors exhibited significant antiproliferative activity against various cancer cell lines, including breast and lung cancer. These results underscore the compound's potential as a scaffold for designing targeted cancer therapies.

The synthetic versatility of (cyclopropylmethyl)hydrazine hydrochloride also extends to its use in click chemistry and bioconjugation. Researchers have leveraged its reactive hydrazine group to develop site-specific labeling strategies for proteins and other biomolecules. A recent publication in Angewandte Chemie (2024) highlighted the compound's utility in constructing stable hydrazone linkages, which are essential for creating bioconjugates with applications in diagnostics and targeted drug delivery. This approach offers advantages such as high selectivity and mild reaction conditions, making it suitable for sensitive biological systems.

Despite its promising applications, challenges remain in the large-scale production and optimization of (cyclopropylmethyl)hydrazine hydrochloride-based compounds. Issues such as stability, solubility, and bioavailability need to be addressed to fully realize its potential in clinical settings. Ongoing research aims to overcome these limitations through structural modifications and formulation strategies. For instance, a 2023 study in ACS Medicinal Chemistry Letters explored the use of prodrug approaches to enhance the delivery of (cyclopropylmethyl)hydrazine hydrochloride-derived therapeutics, yielding encouraging preliminary results.

In conclusion, (cyclopropylmethyl)hydrazine hydrochloride (CAS: 1181457-83-9) represents a valuable building block in modern chemical biology and pharmaceutical research. Its diverse applications—from neurology to oncology and bioconjugation—highlight its significance as a multifunctional reagent. As research continues to uncover new uses and optimize existing ones, this compound is poised to play a pivotal role in the development of innovative therapeutics and diagnostic tools. Future studies should focus on addressing current limitations and expanding its utility in emerging areas such as precision medicine and personalized therapy.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)